NFKB1 and neoplasm: The canonical NF-κB pathway can be activated by various upstream signals induced by extracellular stimuli, including chemotherapeutic agents, to reduce antitumor responses, and inhibiting NF-κB or its upstream signaling can suppress tumor progression or chemoresistance23.